Skip to main content

Month: August 2025

BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results

SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the second quarter of 2025 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2025 with the Securities and Exchange Commission. The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights. Following management’s formal remarks, there will be a question-and-answer session. Recent Business Highlights CardiAMP® autologous cell therapy in ischemic heart failure of reduced ejection fraction (BCDA-01)Two-year results from the double-blind randomized placebo-controlled Phase 3 CardiAMP HF Trial of CardiAMP autologous...

Continue reading

Telos Corporation Announces Second Quarter 2025 Earnings

ASHBURN, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, has posted its 2025 second quarter financial results on its investor relations website at https://investors.telos.com. Telos will host a live webcast to discuss its second quarter 2025 financial results today, August 11, 2025, at 9:30 a.m. ET. To access the webcast, visit https://edge.media-server.com/mmc/p/4zje79ac/lan/en/. Related presentation materials will be made available on the Investors section of the Company’s website at https://investors.telos.com. In addition, an archived webcast will be available approximately two hours after the conclusion of the live event on the Investors section of the Company’s website.  About...

Continue reading

Foresight, KONEC and GINT Collaborate on Prototype Development for Autonomous Tractors Toward Mass Production

Revenue potential of up to $35M by 2030, with initial sales expected in 2026  Ness Ziona, Israel, Aug. 11, 2025 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced today the signing of a three-way agreement with KONEC Ltd. (“KONEC”), a leading South Korean Tier-One automotive supplier, and GINT Ltd. (“GINT”), a South Korean company specializing in automation technologies for agricultural machinery, construction equipment and automobiles, to develop an autonomous control system based on Foresight’s 3D perception technology for autonomous tractors. This follows the agreement with GINT and KONEC, as announced by the Company on December 2, 2024.  The agreement outlines a multi-phase collaboration preparing for mass production...

Continue reading

Cloudastructure CEO James McCormick Featured on “The Big Biz Show”

PALO ALTO, CA, Aug. 11, 2025 (GLOBE NEWSWIRE) — Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”) a recognized leader in AI surveillance and remote guarding solutions today announced that James McCormick, CEO of Cloudastructure participated in an interview with “The Big Biz Show,” an Emmy Award-winning nationally syndicated TV and radio show. During the interview, Mr. McCormick discussed the latest advancements in Cloudastructure’s product offerings, emphasizing the integration of AI as a powerful deterrent—delivering a 98% deterrence rate for a superior security solution. He also shared his vision for the Company’s future and addressed the growing impact of state mandates driving the demand for enhanced security measures. The interview aired on cable TV and streaming services, including...

Continue reading

Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025

Presentation will be the interim data from the Phase 2 study of istaroxime in SEISMiC C – Cardiogenic Shock SCAI Stage C Cardiogenic shock SCAI Stage C has an in hospital mortality rate of 20-30% Istaroxime interim data was consistent with the profile seen in previous studies gives Windtree confidence to move forward with a global Phase 3 study WARRINGTON, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for which the Company is actively seeking long-term development partners, announced that istaroxime was chosen for a presentation entitled, “Safety and Efficacy of intravenous administration of istaroxime for 48 hours in patients...

Continue reading

VivoPower to Procure Underlying 211 million XRP Position Worth $696 million Through Budgeted Initial $100 million Acquisition of Ripple Shares

Backed by investors including Andreessen Horowitz and Google Ventures, Ripple Labs (Ripple) holds 41 billion XRP tokens, representing approximately 41% of all XRP tokens on issue  VivoPower will become the first and only U.S.-listed company to provide exposure to Ripple For $10 million of Ripple shares acquired, an estimated $5.15 of value per share could accrete to VivoPower 1 LONDON, Aug. 11, 2025 (GLOBE NEWSWIRE) — VivoPower International PLC (Nasdaq: VVPR) (“VivoPower” or the “Company”) today announced it is acquiring Ripple Labs (“Ripple”) shares, as part of a strategic enhancement to its XRP-focused digital asset treasury strategy. Following a two-month period of due diligence, VivoPower has budgeted to purchase an initial $100 million of privately held Ripple shares. This encompasses definitive agreements directly with current...

Continue reading

Oragenics Q2 2025 Shareholder Update

Advancing Brain-First Recovery Platform Toward Clinical MilestonesPioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a pioneering biotechnology company striving to develop brain-targeted therapeutics through proprietary intranasal delivery technology, today shared key strategic and financial milestones achieved during the second quarter of 2025 and shortly thereafter. These successes underscore the company’s momentum as it strives to transform neurotrauma care and advance its lead candidate, ONP-002, toward becoming the first FDA-approved pharmacological treatment for concussion. “We’re not just developing another drug, we’re striving to pioneer a new era of brain-first recovery that could transform how we treat neurological...

Continue reading

MIND CTI Reports Second Quarter 2025 Results

YOQNEAM, Israel, Aug. 11, 2025 (GLOBE NEWSWIRE) — MIND C.T.I. LTD. – (NasdaqGM:MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care product-based solutions for service providers, unified communications (UC) analytics and call accounting solutions for enterprises as well as enterprise messaging solutions, today announced results for its second quarter ended June 30, 2025. The following will summarize our major developments in the second quarter of 2025 as well as our business. The financial results can be found in the Company News section of our website at http://www.mindcti.com/company/news/ and in our Form 6-K. Financial HighlightsRevenues were $4.8 million, compared with $5.3 million in the second quarter of 2024, with the decrease mainly attributed to the billing segment. Operating...

Continue reading

Fold Launches Bitcoin Gift Card on Giftcards.com, Expanding Bitcoin Access Across the Nation’s Largest Online Gift Card Marketplace

PHOENIX, Aug. 11, 2025 (GLOBE NEWSWIRE) — Fold Holdings, Inc. (NASDAQ: FLD) (“Fold” or the “Company”), a bitcoin financial services company making it easy for individuals and businesses to earn, save, and spend bitcoin through everyday financial tools, today announced that the Fold Bitcoin Gift Card™ is now available on Giftcards.com, the largest digital gift card retailer in the U.S. and a key platform within Blackhawk Network’s (BHN’s) expansive payments ecosystem. This launch gives Fold access to one of the most heavily trafficked e-commerce destinations in the category, offering millions of consumers direct access to bitcoin in a familiar and frictionless format. The Fold Bitcoin Gift Card™ is the only gift card for bitcoin available on Giftcards.com, underscoring Fold’s leadership in bringing digital assets...

Continue reading

Fluent, Inc. to Attend 45th Annual Canaccord Genuity Growth Conference

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leader in commerce media, today announced that Don Patrick, Chief Executive Officer, will attend the 45th Annual Canaccord Genuity Growth Conference on Wednesday, August 13, 2025, at the InterContinental Boston. Mr. Patrick will participate in a fireside chat at 12:00pm ET on Wednesday, August 13, and is available for one-on-one meetings throughout the day. A live webcast of the fireside chat will be available at the following link:https://wsw.com/webcast/canaccord108/flnt/2525900 A replay of the fireside chat will also be available at the link following the conclusion of the live event. About Fluent, Inc.Fluent, Inc. (NASDAQ: FLNT) is a commerce media solutions provider connecting top-tier brands with highly engaged consumers. Leveraging exclusive ad inventory,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.